fMRI decoded neurofeedback being tested for therapy to reduce PTSD, phobias

Scientists at the ATR Computational Neuroscience Lab in Japan are using a new technique, called fMRI decoded neurofeedback (DecNef) in hopes to treat patients suffering from post-traumatic stress disorder (PTSD) and phobias. 

Data suggests that this approach is somewhat promising because it has helped patients in reducing anxieties triggered by specific memories, without asking them to think about them conciously. 

Lead researcher Mitsuo Kawato hopes that this study will become another way to treat patients. Exposure therapy accounts for a 40 percent drop-out rate amongst PTSD patients.

View full article: 

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.